Rayont Inc- RAYT- Reports Six-Month Ending March 31, 2021, Financial Results.

Palo Alto, California, May 17, 2021 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international healthcare company specializing in the manufacturing of alternative medicine products and services across the entire value chain, today reported financial results for the six-month ended March 31, 2021.

Business Highlights Within the Quarter:

• The appointment of Mr. Reyad Fezzani as non-executive director and Chairperson of its Board of Directors.
• The appointment of Mr. Aleem Sheikh as President and CEO.

Haydn Erbs, Director of Corporate Development and Strategy, said, “The quarter ended March 31, 2021 included the ongoing enhancement of sound corporate governance and internal controls in line with best practice. We have separated the CFO function and CEO role to ensure focused performance delivery and providing greater confidence to shareholders and the investment community”.

Six-month Ending March 31, 2021 Financial Results:

		Six Months Ended March 31,
		2021				2020
Revenues		$	1,409,542			$	844,682
Net Income		$	792,054			$	357,064

Improved Balance Sheet Results

			March 31, 2021				September 30, 2020
Cash		$	79,412			$	196,174
Total Assets		$	5,480,081			$	4,813,688
Total Liabilities		$	1,605,757			$	4,397,956